CoChat

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies

Gambelunghe, Giovanni, Forini, Francesca, Laureti, Stefano, Murdolo, Giuseppe, Toraldo, Gianluca, Santeusanio, Fausto, Brunetti, Paolo, Sanjeevi, Carani B., Falorni, Alberto · 2000 · Clinical Endocrinology
Cited by 108

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Glutamic acid decarboxylase (GAD)65 autoantibodies (GAD65Ab) in type 2 diabetic subjects with secondary failure to sulphonylurea treatment identify the so‐called latent autoimmune diabetes of the adult (LADA). The aim of our study was to estimate the risk for endocrine autoimmunity in type 2 diabetic subjects with GAD65Ab. DESIGN AND PATIENTS: We analysed serum samples from 600 adult subjects with a clinical diagnosis of type 2 diabetes mellitus for the presence and levels of GAD65Ab and antibodies directed against the islet autoantigen IA‐2/ICA512 (IA‐2/ICA512Ab). All the patients had been treated initially with hypoglycaemic agents and/or diet for at least 1 year. GAD65Ab+ subjects were studied for the presence of thyroid peroxidase autoantibodies (TPOAb), 21 hydroxylase autoantibodies (21OHAb) and frequency of HLA class II haplotypes. RESULTS: GAD65Ab were found in 67/600 (11%) and IA‐2/ICA512Ab in 12/600 (2%) subjects (P < 0.0001). The presence of GAD65Ab, but not that of IA‐2/ICA512Ab, was significantly associated with insulin therapy, low BMI (P < 0.0001) and low basal C‐peptide (P < 0.01). Islet‐cell antibodies (ICA) were detected in 43/67 (64%) GAD65Ab+ and in 10/12 (83%) IA‐2/ICA512Ab + subjects. TPOAb occurred more frequently in GAD65Ab+ (16/67, 24%) than in GAD65Ab‐subjects (9/174, 5%) (P < 0.0001). 21OHAb were detected only in GAD65Ab+ subjects (3/67, 4.5%) (P = 0.03 vs. GAD65 A b‐subjects). None of the 21OHAb+ subjects had metabolic or clinical signs of adrenal dysfunction. HLA‐DRB1*03‐DQA1*0501‐DQB1*0201 (DR3‐DQ2) was significantly more frequent in GAD65Ab+ subjects than in healthy controls (O R = 5.42, corrected P < 0.0026). The presence of TPOAb was significantly associated with DR3‐DQ2 (P = 0.024). CONCLUSIONS: Our study demonstrates that the presence of GAD65Ab identifies a subgroup of type 2 diabetic patients with high risk for thyroid and adrenal autoimmunity, and that both GAD65Ab and TPOAb are associated with the presence of HLA‐DR3‐DQ2, in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2000.00983.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 108

Metadata

Authors
Gambelunghe, G., Forini, F., Laureti, S., Murdolo, G., Toraldo, G., Santeusanio, F., Brunetti, P., Sanjeevi, C. B., & Falorni, A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2000-05-19
Volume
52
Issue
5
Pages
565-573
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2092847594
Cited by
108
References
5
FWCI
3.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. https://app.cochat.ai/papers/10.1046/j.1365-2265.2000.00983.x
The paper
Gambelunghe, G., Forini, F., Laureti, S., Murdolo, G., Toraldo, G., Santeusanio, F., Brunetti, P., Sanjeevi, C. B., & Falorni, A. (2000). Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2000.00983.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.